Glucose Health, Inc. (“GLUC” or the “Company”) today announced the uploading of a new quarterly letter to shareholders which, among items relating to the achievement of various corporate milestones, highlights the disruptive characteristics of the Company’s namesake product, Glucose Health® Natural Blood Sugar Maintenance:
The quarterly letter to shareholders, which was written by Glucose Health, Inc. CEO, Murray Fleming, can be read at www.glucosehealthinc.com/ceo-quarterly-letter.
The uploading of the letter follows the filing of the Company’s Form 10-Q for the period ending March 31, 2015. Glucose Health, Inc., being subject to the Securities Act of 1934, files the very same periodic reports, such as Form 10-Q, as well as annual audited financial statements and timely material information disclosures, as other public companies, including those trading on the NASDAQ or New York Stock Exchange.
About Glucose Health, Inc. (OTCQB: GLUC)
Glucose Health® engages the large and growing market of consumers aware of the seriousness of Type-2 diabetes and proactively seeking natural blood sugar health solutions. Glucose Health® is marketed via selected pharmacy retailer partners and the Company’s informative product website www.glucosehealth.com. Glucose Health, Inc. is headquartered in Bentonville, Arkansas.
For more information about Glucose Health, Inc. please also visit the corporate website at www.glucosehealthinc.com.
1www.glucosehealth.com/clinical-trials
View source version on businesswire.com: http://www.businesswire.com/news/home/20150603005161/en/